1. Home
  2. SEPN vs LYTS Comparison

SEPN vs LYTS Comparison

Compare SEPN & LYTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SEPN
  • LYTS
  • Stock Information
  • Founded
  • SEPN 2022
  • LYTS 1976
  • Country
  • SEPN United States
  • LYTS United States
  • Employees
  • SEPN N/A
  • LYTS N/A
  • Industry
  • SEPN
  • LYTS Building Products
  • Sector
  • SEPN
  • LYTS Consumer Discretionary
  • Exchange
  • SEPN NYSE
  • LYTS Nasdaq
  • Market Cap
  • SEPN 631.0M
  • LYTS 551.1M
  • IPO Year
  • SEPN 2024
  • LYTS N/A
  • Fundamental
  • Price
  • SEPN $5.80
  • LYTS $19.26
  • Analyst Decision
  • SEPN Buy
  • LYTS Strong Buy
  • Analyst Count
  • SEPN 4
  • LYTS 2
  • Target Price
  • SEPN $34.00
  • LYTS $28.00
  • AVG Volume (30 Days)
  • SEPN 857.5K
  • LYTS 168.2K
  • Earning Date
  • SEPN 02-28-2025
  • LYTS 01-23-2025
  • Dividend Yield
  • SEPN N/A
  • LYTS 1.04%
  • EPS Growth
  • SEPN N/A
  • LYTS N/A
  • EPS
  • SEPN N/A
  • LYTS 0.76
  • Revenue
  • SEPN $981,000.00
  • LYTS $523,020,999.00
  • Revenue This Year
  • SEPN $406.62
  • LYTS $20.24
  • Revenue Next Year
  • SEPN N/A
  • LYTS $7.64
  • P/E Ratio
  • SEPN N/A
  • LYTS $25.32
  • Revenue Growth
  • SEPN N/A
  • LYTS 10.45
  • 52 Week Low
  • SEPN $4.17
  • LYTS $13.63
  • 52 Week High
  • SEPN $28.99
  • LYTS $25.50
  • Technical
  • Relative Strength Index (RSI)
  • SEPN N/A
  • LYTS 39.27
  • Support Level
  • SEPN N/A
  • LYTS $19.68
  • Resistance Level
  • SEPN N/A
  • LYTS $21.24
  • Average True Range (ATR)
  • SEPN 0.00
  • LYTS 0.60
  • MACD
  • SEPN 0.00
  • LYTS -0.19
  • Stochastic Oscillator
  • SEPN 0.00
  • LYTS 0.43

About SEPN SEPTERNA INC

Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, and GLP-1R, GIPR, GCGR.

About LYTS LSI Industries Inc.

LSI Industries Inc provides corporate visual image solutions to the petroleum and convenience store industry. The company's operating segments include Lighting and Display Solutions. It generates maximum revenue from the Lighting segment. Lighting Segment manufactures and markets outdoor and indoor lighting and lighting controls for the commercial, industrial, and multi-site retail markets including the petroleum/convenience store, quick-service, and automotive markets. The Display Solutions Segment manufactures, sells and installs exterior and interior visual image and display elements, including printed graphics, structural graphics, digital signage, menu board systems, display fixtures, refrigerated displays, and custom display elements.

Share on Social Networks: